The Latest Trading Price of Hemo Organic Ltd is ₹ 21.85 as of 26 Oct 15:30
. The P/E Ratio of Hemo Organic Ltd is 0 as of March 2024
.The P/E Ratio of Yogi Ltd is 0 as of March 2024
. The Market Cap of Hemo Organic Ltd is ₹ 0 crore as of March 2024
.The Market Cap of Yogi Ltd is ₹ 101.1 crore as of March 2024
. The revenue of Hemo Organic Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Yogi Ltd for the Jun '26 is ₹ 49.81 crore as compare to the Mar '26 revenue of ₹ 158.32 crore. This represent the decline of -68.54% The ebitda of Hemo Organic Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Yogi Ltd for the Jun '26 is ₹ 2.47 crore as compare to the Mar '26 ebitda of ₹ 7.99 crore. This represent the decline of -69.09% The net profit of Hemo Organic Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The net profit of Yogi Ltd changed from ₹ -0.16 crore to ₹ -1.62 crore over 9 quarters. This represents a CAGR of 179.80%
The Dividend Payout of Hemo Organic Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Yogi Ltd changed from 5.34 % on March 2026 to 5.34 % on March 2026 . This represents a CAGR of 0.00% over 1 years .
About Hemo Organic Ltd
Hemo Organic Limited was initially incorporated as 'Dinesh Allorga Limited' in August, 1992, which engaged in manufacturing of chemicals having plant and machinery at Lunej, Khambhat, Gujarat.
The manufacturing of the same was discontinued due to pollution crisis.
But the same was discontinued due to pollution crisis.
Thereafter, the Company changed its name to Hemo Organic Limited on August 19, 2013.
Currently, Company engages in Trading Activity of 'Rice' &'Textile'.
The Company is setting up a new project to manufacture 2.6 Di Chloro Aniline which is used as an intermediate in bulk drugs/ pharmaceuticals and Para Chloro Meta Cresol which is used in the leather industry.
About Yogi Ltd
Yogi Limited was initially established in December, 1992 as Parsharti Investment Limited.
The name of the Company was changed from Parsharti Investment Limited to Yogi Limited on 16th June, 2022.
The Company is primarily engaged in the business of real estate development, construction, contracting, building, town planning, infrastructure development, and estate development.
Its activities encompass a broad spectrum of projects including the planning, design, execution, and delivery of high-quality real estate and infrastructure assets.
The Company has undertaken and continues to undertake projects such as residential layout schemes, slum rehabilitation and redevelopment projects (SRA) in Mumbai, and other allied real estate development initiatives, which contribute significantly to urban growth and housing solutions.
FAQs for the comparison of Hemo Organic Ltd and Yogi Ltd
Which company has a larger market capitalization, Hemo Organic Ltd or Yogi Ltd?
Market cap of Hemo Organic Ltd is 7 Cr while Market cap of Yogi Ltd is 688 Cr
What are the key factors driving the stock performance of Hemo Organic Ltd and Yogi Ltd?
The stock performance of Hemo Organic Ltd and Yogi Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Hemo Organic Ltd and Yogi Ltd?
As of October 31, 2026, the Hemo Organic Ltd stock price is INR ₹21.85. On the other hand, Yogi Ltd stock price is INR ₹152.99.
How do dividend payouts of Hemo Organic Ltd and Yogi Ltd compare?
To compare the dividend payouts of Hemo Organic Ltd and Yogi Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.